Wednesday, June 17, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 321 of 1,261
  1. US 11096927

    Anti-flavivirus compounds and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  2. US 11096864

    Adapter for a dispensing container in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Granted Aug 24, 2021 · Expires Aug 19, 2041

    granted
  3. US 11090310

    Methods and compositions for treating hypertriglyceridemia

    The Regents of the University of California · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  4. US 11090224

    Adaptor for a dispensing container in a planetary mixer

    MEDISCA PHARMACEUTIQUE INC. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  5. US 11090286

    Methods of treating and preventing breast cancer with S-equol

    The Board of Regents of the University of Texas System · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  6. US 11090290

    Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy

    Monopar Therapeutics Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  7. US 11090326

    Fixed-dose pharmaceutical composition comprising rifabutin, clarithromycin, and clofazimine

    RedHill Biopharma Ltd. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  8. US 11090325

    Compositions for treating ebola virus infection

    RedHill Biopharma Ltd. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  9. US 11090293

    Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering

    OVID THERAPEUTICS INC. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  10. US 11091795

    Compositions and methods for diagnosing and treating arrhythmias

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  11. US 11091761

    Organic compositions to treat HSF1-related diseases

    Arrowhead Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  12. US 11091561

    HER-2 binding antibodies

    MAB Discovery GmbH · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  13. US 11091555

    Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy

    Five Prime Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  14. US 11091532

    T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen receptor

    AUTOLUS LIMITED · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  15. US 11091534

    Factor VIII complex with XTEN and von Willebrand Factor protein, and uses thereof

    BIOVERATIV THERAPEUTICS INC. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  16. US 11091529

    Peptides having reduced toxicity that stimulate cholesterol efflux

    The Regents of the University of California · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  17. US 11091519

    Purification of virus like particles

    Takeda Vaccines, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  18. US 11091518

    Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same

    Inovio Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  19. US 11091516

    Synthetic binder of breast cancer stem cells

    The Board of Regents of the University of Texas System · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  20. US 11091509

    HPPK inhibitors useful as antibacterial agents

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  21. US 11091501

    Heterocyclic compounds as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  22. US 11091495

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors

    Mirati Therapeutics, Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  23. US 11091473

    Compounds for pain treatment, compositions comprising same, and methods of using same

    ACADIA Pharmaceuticals Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted
  24. US 11091441

    Solid state crystalline forms of a selective potassium channel modulator

    Xenon Pharmaceuticals Inc. · Granted Aug 17, 2021 · Expires Aug 12, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.